The medical world is observing a major shift in glucose therapy with the emergence of GLP-1 skin applications. These systems offer a seemingly more user-friendly alternative to injections of GLP-1 drugs, minimizing the need for daily needle pokes. The technology delivers the drug directly through the skin, arguably improving individual adherence an